Prospective repair of Ventral Hernia Working Group type 3 and 4 abdominal wall defects with condensed polytetrafluoroethylene (MotifMESH) mesh

Am J Surg. 2016 Jan;211(1):1-10. doi: 10.1016/j.amjsurg.2015.03.033. Epub 2015 Jun 15.

Abstract

Background: Treatment of clean-contaminated and contaminated ventral hernia defects remains controversial. Newer prosthetic materials may play an important role in these patients.

Methods: Ten patients with Ventral Hernia Working Group types 3 and 4 were prospectively enrolled and subsequently treated with direct supported repairs with condensed fenestrated polytetrafluoroethylene mesh. The primary outcome was hernia occurrence at 1 year after surgery. Secondary outcomes included surgical site infection, surgical site occurrence, medical complications, pain, and other patient-reported outcomes.

Results: There were no immediate postoperative infections and one minor postoperative hematoma treated in the office. One patient required delayed mesh removal 9 months after placement. Importantly, the mesh removal procedure was straightforward because of the material properties of the mesh. Of the 9 patients still with mesh, there were no hernia recurrences at the repair site with one full year of follow-up.

Conclusion: Contaminated and clean-contaminated abdominal wall defects can be effectively and durably treated with condensed polytetrafluoroethylene mesh.

Keywords: Mesh; Surgical site infection; Surgical site occurrence; Ventral hernia.

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Wall / surgery
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Hernia, Ventral / surgery*
  • Herniorrhaphy / instrumentation*
  • Herniorrhaphy / methods
  • Humans
  • Male
  • Middle Aged
  • Polytetrafluoroethylene*
  • Prospective Studies
  • Recurrence
  • Surgical Mesh*
  • Surgical Wound Infection
  • Treatment Outcome

Substances

  • Polytetrafluoroethylene